Protara Beats Q2 Loss Estimates
Protara Therapeutics (NASDAQ:TARA) reported a narrower-than-expected GAAP net loss per share of $0.35 for Q2 2025, with revenue remaining at ...
Tag: Protara
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.